製品の概要

製品の詳細

  • 由来Recombinant
  • 由来Escherichia coli
  • アミノ酸配列
    • アクセッション番号P13987
    • 生物種Human
    • 配列YNCPNPTADCKTAVNCSSDFDACLITKAGLQVYNKCWKFEHCNFNDVTTR LRENELTYYCCKKDLCNFNEQLEN
    • 分子量9 kDa
    • 領域29 to 102

特性

Our Abpromise guarantee covers the use of ab126011 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    SDS-PAGE

  • 製品の状態Lyophilised
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Store at -20°C.

    Constituents: 0.32% Tris HCl, 0.58% Sodium chloride

  • 再構成Reconstitute with water to desired concentration.

関連情報

  • 別名
    • 16.3A5
    • 1F5
    • 1F5 antigen
    • 20 kDa homologous restriction factor
    • CD 59
    • CD_antigen=CD59
    • CD59
    • CD59 antigen
    • CD59 antigen complement regulatory protein
    • CD59 antigen p18 20
    • CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344)
    • CD59 glycoprotein
    • CD59 molecule
    • CD59 molecule complement regulatory protein
    • CD59_HUMAN
    • Cd59a
    • Complement regulatory protein
    • EJ16
    • EJ30
    • EL32
    • FLJ38134
    • FLJ92039
    • G344
    • HRF 20
    • HRF-20
    • HRF20
    • Human leukocyte antigen MIC11
    • Ly 6 like protein
    • Lymphocytic antigen CD59/MEM43
    • MAC inhibitory protein
    • MAC IP
    • MAC-inhibitory protein
    • MAC-IP
    • MACIF
    • MACIP
    • MEM43
    • MEM43 antigen
    • Membrane attack complex (MAC) inhibition factor
    • Membrane attack complex inhibition factor
    • Membrane inhibitor of reactive lysis
    • MGC2354
    • MIC11
    • MIN1
    • MIN2
    • MIN3
    • MIRL
    • MSK21
    • p18 20
    • Protectin
    • Surface antigen recognized by monoclonal antibody 16.3A5
    • T cell activating protein
    see all
  • 機能Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase.
    The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes.
  • 関連疾患Defects in CD59 are the cause of CD59 deficiency (CD59D) [MIM:612300].
  • 配列類似性Contains 1 UPAR/Ly6 domain.
  • 翻訳後修飾N- and O-glycosylated. The N-glycosylation mainly consists of a family of biantennary complex-type structures with and without lactosamine extensions and outer arm fucose residues. Also significant amounts of triantennary complexes (22%). Variable sialylation also present in the Asn-43 oligosaccharide. The predominant O-glycans are mono-sialylated forms of the disaccharide, Gal-beta-1,3GalNAc, and their sites of attachment are probably on Thr-76 and Thr-77. The GPI-anchor of soluble urinary CD59 has no inositol-associated phospholipid, but is composed of seven different GPI-anchor variants of one or more monosaccharide units. Major variants contain sialic acid, mannose and glucosamine Sialic acid linked to an N-acetylhexosamine-galactose arm is present in two variants.
    Glycated. Glycation is found in diabetic subjects, but only at minimal levels in nondiabetic subjects. Glycated CD59 lacks MAC-inhibitory function and confers to vascular complications of diabetes.
  • 細胞内局在Cell membrane. Secreted. Soluble form found in a number of tissues.
  • Information by UniProt

Recombinant Human CD59 protein (ab126011) 使用論文

ab126011 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab126011.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"